Precision Medicine and Targeted Therapies in Breast Cancer.
Surg Oncol Clin N Am
; 29(1): 51-62, 2020 01.
Article
en En
| MEDLINE
| ID: mdl-31757313
ABSTRACT
Precision medicine and targeted therapies have a long history in the treatment of breast cancer and continue to show promise for further specialized and individualized care for this disease. From the discovery of endocrine and HER2 targeted therapies, to multigene arrays in chemotherapy for more specific patient selection, to radiomics and genetic subtyping, targeted therapies and precision medicine continue to push the management of breast cancer toward more individualized care. This article describes the foundation and future of targeted therapy and precision medicine in breast cancer.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Farmacogenética
/
Neoplasias de la Mama
/
Biomarcadores de Tumor
/
Medicina de Precisión
/
Terapia Molecular Dirigida
/
Antineoplásicos
Tipo de estudio:
Prognostic_studies
Límite:
Female
/
Humans
Idioma:
En
Revista:
Surg Oncol Clin N Am
Asunto de la revista:
NEOPLASIAS
Año:
2020
Tipo del documento:
Article
País de afiliación:
Estados Unidos